Showing results (1841-1850 of 1,961) with videos related to
Sort By:
Pageof 197
Journal of Dental Research|January 13, 2018
Oral Sciences PhD Program Enrollment, Graduates, and Placement: 1994 to 2016C R Herzog, D W Berzins, P DenBesten, et al.Urology Practice|February 27, 2023
An Assessment Tool to Provide Targeted Feedback to Robotic Surgical Trainees: Development and Validation of the End-To-End Assessment of Suturing Expertise (EASE)Taseen F Haque, Alvin Hui, Jonathan You, et al.Geohealth|April 3, 2026
Developing Scenario-Based Strategies for Health, Climate, and Environmental Preparedness: The One Health, One Earth ApproachAzar M Abadi, Kyle D Brumfield, Moiz Usmani, et al.The Journal of Trauma|May 26, 2011
Blunt traumatic occult pneumothorax: is observation safe?--results of a prospective, AAST multicenter studyForrest O Moore, Pamela W Goslar, Raul Coimbra, et al.Molecular Psychiatry|November 17, 2010
Parental psychopathology and the risk of suicidal behavior in their offspring: results from the World Mental Health surveysO Gureje, B Oladeji, I Hwang, et al.The Journal of Urology|August 26, 2021
Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 ConsortiumPeter Chang, Andrew A Wagner, Meredith M Regan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 27, 2025
9MW2821, a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open label, multicenter, phase Ⅰ/Ⅱ studyJ Zhang, R Liu, S Wang, et al.European Urology Oncology|June 10, 2025
A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single InstitutionHimanshu Nagar, Marshall A Diven, Brady Rippon, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2019
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432F Wang, X L Wei, F H Wang, et al.European Urology|January 11, 2024
Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized TrialJim C Hu, Melissa Assel, Mohamad E Allaf, et al.Pageof 197